IDH1 and IDH2 Mutations in Gliomas
Yan, Hai, Parsons, D. Williams, Jin, Genglin, McLendon, Roger, Rasheed, B. Ahmed, Yuan, Weishi, Kos, Ivan, Batinic-Haberle, Ines +10 more·2009·New England Journal of Medicine
Cited by (1,012)
Items 1,001–1,012 of 1,012
- Interactions between epigenetics and metabolism in cancersYun, Jihye, Johnson, Jared L., Hanigan, Christin L., Locasale, Jason W. · 2012 · Frontiers in Oncology
- A high-throughput fluorimetric assay for 2-hydroxyglutarate identifies Zaprinast as a glutaminase inhibitorElhammali, Adnan, Ippolito, Joseph E., Collins, Lynne, Crowley, Jan, Marasa, Jayne, Piwnica-Worms, David · 2014 · Cancer Discovery
- 2-HG Inhibits Necroptosis by Stimulating DNMT1-Dependent Hypermethylation of the RIP3 PromoterYang, Zhentao, Jiang, Bin, Wang, Yan, Ni, Hengxiao, Zhang, Jia, Xia, Jinmei, Shi, Minggang, Hung, Li-Man, Ruan, Jingsong, Mak, Tak Wah et al. · 2017 · Cell Reports
- Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapyAmoedo, N.D., Obre, E., Rossignol, R. · 2017 · Biochimica et Biophysica Acta (BBA) - Bioenergetics
- <i>IDH</i>
Mutation Subgroup Status Associates with Intratumor Heterogeneity and the Tumor Microenvironment in Intrahepatic CholangiocarcinomaXiang, Xiao, Liu, Ziyang, Zhang, Chong, Li, Zhao, Gao, Jie, Zhang, Changkun, Cao, Qi, Cheng, Jinghui, Liu, Hengkang, Chen, Dingbao et al. · 2021 · Advanced Science
- Non-Invasive Tumor Genotyping Using Radiogenomic Biomarkers, a Systematic Review and Oncology-Wide Pathway AnalysisJansen, Robin W., van Amstel, Paul, Martens, Roland M., Kooi, Irsan E., Wesseling, Pieter, de Langen, Adrianus J., Menke-Van der Houven van Oordt, Catharina W., Jansen, Bernard H.E., Moll, Annette C., Dorsman, Josephine C. et al. · 2018 · Oncotarget
- Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterationsFigarella-Branger, D., Mokhtari, K., Dehais, C., Jouvet, A., Uro-Coste, E., Colin, C., Carpentier, C., Forest, F., Maurage, C.-A., Vignaud, J.-M. et al. · 2014 · Neuro-Oncology
- IDH2 and NPM1 Mutations Cooperate to Activate Hoxa9/Meis1 and Hypoxia Pathways in Acute Myeloid LeukemiaOgawara, Yoko, Katsumoto, Takuo, Aikawa, Yukiko, Shima, Yutaka, Kagiyama, Yuki, Soga, Tomoyoshi, Matsunaga, Hironori, Seki, Takahiko, Araki, Kazushi, Kitabayashi, Issay · 2015 · Cancer Research
- Biologically interpretable multi-task deep learning pipeline predicts molecular alterations, grade, and prognosis in glioma patientsWu, Xuewei, Zhang, Shuaitong, Zhang, Zhenyu, He, Zicong, Xu, Zexin, Wang, Weiwei, Jin, Zhe, You, Jingjing, Guo, Yang, Zhang, Lu et al. · 2024 · npj Precision Oncology
- IDH1 Mutation Promotes Tumorigenesis by Inhibiting JNK Activation and Apoptosis Induced by Serum StarvationJiang, Bin, Zhang, Jia, Xia, Jinmei, Zhao, Wentao, Wu, Yanan, Shi, Minggang, Luo, Lianzhong, Zhou, Huamin, Chen, Ai, Ma, Huanhuan et al. · 2017 · Cell Reports
- Wilms Tumor in a Child with L-2-hydroxyglutaric AciduriaRogers, Robert E., DeBerardinis, Ralph J., Klesse, Laura J., Boriack, Richard L., Margraf, Linda R., Rakheja, DINESH · 2010 · Pediatric and Developmental Pathology
- Indications for Treatment: Is Observation or Chemotherapy Alone a Reasonable Approach in the Management of Low-Grade Gliomas?Schaff, Lauren R., Lassman, Andrew B. · 2015 · Seminars in Radiation Oncology